A retrospective analysis of glycol and toxic alcohol ingestion: utility of anion and osmolal gaps

Kraut JA, Kurtz I: Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol. 2008, 3: 208-225. 10.2215/CJN.03220807.

Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA: American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002, 40: 415-446. 10.1081/CLT-120006745.

Barceloux DG, Krenzelok EP, Olson K, Watson W: American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Ethylene Glycol Poisoning. Ad Hoc Committee. J Toxicol Clin Toxicol. 1999, 37: 537-560. 10.1081/CLT-100102445.

Jammalamadaka D, Raissi S: Ethylene glycol, methanol and isopropyl alcohol intoxication. Am J Med Sci. 2010, 339: 276-281. 10.1097/MAJ.0b013e3181c94601.

Kruse JA: Methanol poisoning. Intensive Care Med. 1992, 18: 391-397. 10.1007/BF01694340.

Wu AH, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, Otten EM, Welch SL, Wax P: National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003, 49: 357-379. 10.1373/49.3.357.

Litovitz T: The alcohols: ethanol, methanol, isopropanol, ethylene glycol. Pediatr Clin North Am. 1986, 33: 311-323.

Monaghan MS, Ackerman BH, Olsen KM, Farmer C, Pappas AA: The use of delta osmolality to predict serum isopropanol and acetone concentrations. Pharmacotherapy. 1993, 13: 60-63.

Brent J, McMartin K, Phillips S, Aaron C, Kulig K: Fomepizole for the treatment of methanol poisoning. N Engl J Med. 2001, 344: 424-429. 10.1056/NEJM200102083440605.

Brent J, McMartin K, Phillips S, Burkhart KK, Donovan JW, Wells M, Kulig K: Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. N Engl J Med. 1999, 340: 832-838. 10.1056/NEJM199903183401102.

Koga Y, Purssell RA, Lynd LD: The irrationality of the present use of the osmole gap: applicable physical chemistry principles and recommendations to improve the validity of current practices. Toxicol Rev. 2004, 23: 203-211. 10.2165/00139709-200423030-00006.

Krahn J, Khajuria A: Osmolality gaps: diagnostic accuracy and long-term variability. Clin Chem. 2006, 52: 737-739. 10.1373/clinchem.2005.057695.

Bhagat CI, Garcia-Webb P, Fletcher E, Beilby JP: Calculated vs measured plasma osmolalities revisited. Clin Chem. 1984, 30: 1703-1705.

Coakley JC, Tobgui S, Dennis PM: Screening for alcohol intoxication by the osmolar gap. Pathology. 1983, 15: 321-323. 10.3109/00313028309083513.

Dorwart WV, Chalmers L: Comparison of methods for calculating serum osmolality form chemical concentrations, and the prognostic value of such calculations. Clin Chem. 1975, 21: 190-194.

Eisen TF, Lacouture PG, Woolf A: Serum osmolality in alcohol ingestions: differences in availability among laboratories of teaching hospital, nonteaching hospital, and commercial facilities. Am J Emerg Med. 1989, 7: 256-259. 10.1016/0735-6757(89)90164-2.

Galvan LA, Watts MT: Generation of an osmolality gap-ethanol nomogram from routine laboratory data. Ann Emerg Med. 1992, 21: 1343-1348. 10.1016/S0196-0644(05)81899-2.

Geller RJ, Spyker DA, Herold DA, Bruns DE: Serum osmolal gap and ethanol concentration: a simple and accurate formula. J Toxicol Clin Toxicol. 1986, 24: 77-84. 10.3109/15563658608990448.

Glaser DS: Utility of the serum osmol gap in the diagnosis of methanol or ethylene glycol ingestion. Ann Emerg Med. 1996, 27: 343-346. 10.1016/S0196-0644(96)70271-8.

Hoffman RS, Smilkstein MJ, Howland MA, Goldfrank LR: Osmol gaps revisited: normal values and limitations. J Toxicol Clin Toxicol. 1993, 31: 81-93. 10.3109/15563659309000375.

Khajuria A, Krahn J: Osmolality revisited--deriving and validating the best formula for calculated osmolality. Clin Biochem. 2005, 38: 514-519. 10.1016/j.clinbiochem.2005.03.001.

Lynd LD, Richardson KJ, Purssell RA, Abu-Laban RB, Brubacher JR, Lepik KJ, Sivilotti ML: An evaluation of the osmole gap as a screening test for toxic alcohol poisoning. BMC Emerg Med. 2008, 8: 5-10.1186/1471-227X-8-5.

Osterloh JD, Kelly TJ, Khayam-Bashi H, Romeo R: Discrepancies in osmolal gaps and calculated alcohol concentrations. Arch Pathol Lab Med. 1996, 120: 637-641.

Osypiw JC, Watson ID, Gill G: What is the best formula for predicting osmolar gap?. Ann Clin Biochem. 1997, 34 (Pt 5): 551-552.

Purssell RA, Lynd LD, Koga Y: The use of the osmole gap as a screening test for the presence of exogenous substances. Toxicol Rev. 2004, 23: 189-202. 10.2165/00139709-200423030-00005.

Purssell RA, Pudek M, Brubacher J, Abu-Laban RB: Derivation and validation of a formula to calculate the contribution of ethanol to the osmolal gap. Ann Emerg Med. 2001, 38: 653-659. 10.1067/mem.2001.119455.

Silvilotti ML, Collier CP, Choi SB: Ethanol and the osmolal gap. Ann Emerg Med. 2002, 40: 656-657; author reply 657-658. 10.1067/mem.2002.129718.

Snyder H, Williams D, Zink B, Reilly K: Accuracy of blood ethanol determination using serum osmolality. J Emerg Med. 1992, 10: 129-133. 10.1016/0736-4679(92)90205-8.

Worthley LI, Guerin M, Pain RW: For calculating osmolality, the simplest formula is the best. Anaesth Intensive Care. 1987, 15: 199-202.

Almaghamsi AM, Yeung CK: Osmolal gap in alcoholic ketoacidosis. Clin Nephrol. 1997, 48: 52-53.

Braden GL, Strayhorn CH, Germain MJ, Mulhern JG, Skutches CL: Increased osmolal gap in alcoholic acidosis. Arch Intern Med. 1993, 153: 2377-2380. 10.1001/archinte.1993.00410200103013.

Renom G, Maisonneuve N, Kim I, Dehon B, Azar R: Major ketogenesis and the absence of an osmolar gap in an atypical case of alcoholic ketoacidosis. Ann Clin Biochem. 2003, 40: 424-426. 10.1258/000456303766477110.

Garcia-Morales EJ, Cariappa R, Parvin CA, Scott MG, Diringer MN: Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med. 2004, 32: 986-991. 10.1097/01.CCM.0000120057.04528.60.

Huff JS: Acute mannitol intoxication in a patient with normal renal function. Am J Emerg Med. 1990, 8: 338-339. 10.1016/0735-6757(90)90091-D.

Dursun H, Noyan A, Cengiz N, Attila G, Buyukcelik M, Soran M, Seydaoglu G, Bayazit AK, Anarat A: Changes in osmolal gap and osmolality in children with chronic and end-stage renal failure. Nephron Physiol. 2007, 105: 19-21. 10.1159/000097604.

Sklar AH, Linas SL: The osmolal gap in renal failure. Ann Intern Med. 1983, 98: 481-482.

Gill GV, Osypiw JC, Shearer E, English PJ, Watson ID: Critical illness with hyponatraemia and impaired cell membrane integrity--the "sick cell syndrome" revisited. Clin Biochem. 2005, 38: 1045-1048. 10.1016/j.clinbiochem.2005.07.014.

Guglielminotti J, Pernet P, Maury E, Alzieu M, Vaubourdolle M, Guidet B, Offenstadt G: Osmolar gap hyponatremia in critically ill patients: evidence for the sick cell syndrome?. Crit Care Med. 2002, 30: 1051-1055. 10.1097/00003246-200205000-00016.

Zar T, Graeber C, Perazella MA: Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dial. 2007, 20: 217-219. 10.1111/j.1525-139X.2007.00280.x.

Brooks DE, Wallace KL: Acute propylene glycol ingestion. J Toxicol Clin Toxicol. 2002, 40: 513-516. 10.1081/CLT-120006755.

Al-Khafaji AH, Dewhirst WE, Manning HL: Propylene glycol toxicity associated with lorazepam infusion in a patient receiving continuous veno-venous hemofiltration with dialysis. Anesth Analg. 2002, 94: 1583-1585.

Arbour RB: Propylene glycol toxicity related to high-dose lorazepam infusion: case report and discussion. Am J Crit Care. 1999, 8: 499-506.

Chicella M, Jansen P, Parthiban A, Marlowe KF, Bencsath FA, Krueger KP, Boerth R: Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients. Crit Care Med. 2002, 30: 2752-2756. 10.1097/00003246-200212000-00021.

Parker MG, Fraser GL, Watson DM, Riker RR: Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy. Intensive Care Med. 2002, 28: 81-84. 10.1007/s00134-001-1125-1.

Wilson KC, Reardon C, Theodore AC, Farber HW: Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest. 2005, 128: 1674-1681. 10.1378/chest.128.3.1674.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem. 2003, 49: 1-6. 10.1373/49.1.1.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG: The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003, 49: 7-18. 10.1373/49.1.7.

Fulop M: Alcoholic ketoacidosis. Endocrinol Metab Clin North Am. 1993, 22: 209-219.

McGuire LC, Cruickshank AM, Munro PT: Alcoholic ketoacidosis. Emerg Med J. 2006, 23: 417-420. 10.1136/emj.2004.017590.

Haviv YS, Rubinger D, Zamir E, Safadi R: Pseudo-normal osmolal and anion gaps following simultaneous ethanol and methanol ingestion. Am J Nephrol. 1998, 18: 436-438. 10.1159/000013366.

Burkitt JM, Haskins SC, Aldrich J, Jandrey KE, Rezende ML, Boyle JE: Effects of oral administration of a commercial activated charcoal suspension on serum osmolality and lactate concentration in the dog. J Vet Intern Med. 2005, 19: 683-686. 10.1111/j.1939-1676.2005.tb02746.x.